Amazon (NASDAQ: AMZN) has skyrocketed by close to 50% so far this year. On average, analysts surveyed by Refinitiv forecast that Amazon's earnings per share will grow at a whopping 79% annualized rate over the next five years. The tech giant's biggest growth opportunity comes from Amazon Web Services (AWS).
What happened Shares of Editas Medicine (NASDAQ: EDIT) were soaring 11.2% higher as of 10:41 a.m. ET on Friday after vaulting as much as 24% earlier in the day. The big gain came after Stifel analyst Dae Gon Ha upgraded the stock from hold to buy.
Based on the average brokerage recommendation (ABR), Vertex (VRTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?